Shuttle Pharmaceuticals Holdings (SHPH) Non-Current Debt (2021 - 2023)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Non-Current Debt of $139229.0 for Q1 2023, up 90.71% quarter-over-quarter from $73007.0 in Q4 2022.
Shuttle Pharmaceuticals Holdings (SHPH) Non-Current Debt (2021 - 2023) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Non-Current Debt history runs 3 years deep, the most recent figure standing at $139229.0 for Q1 2023.
- In Q1 2023, Non-Current Debt changed N/A year-over-year to $139229.0; the TTM figure through Mar 2023 stood at $139229.0 (changed N/A YoY), while the FY2022 annual figure was $73007.0, changed 0.0% from the prior year.
- Non-Current Debt for Q1 2023 stood at $139229.0, up from $73007.0 in the prior quarter.
- The five-year high for Non-Current Debt was $139229.0 in Q1 2023, with the low at $73007.0 in Q4 2021.
- The 3-year median for Non-Current Debt is $73007.0 (2021), against an average of $89562.5.
- Peak annual rise in Non-Current Debt reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Shuttle Pharmaceuticals Holdings' Non-Current Debt stood at $73007.0 in 2021, then changed by 0.0% to $73007.0 in 2022, then surged by 90.71% to $139229.0 in 2023.
- Business Quant data shows SHPH's Non-Current Debt at $139229.0 in Q1 2023, $73007.0 in Q4 2022, and $73007.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 130.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 139,229.00 |
| Dec 31, 2022 | 73,007.00 |
| Sep 30, 2022 | 73,007.00 |
| Dec 31, 2021 | 73,007.00 |